Breaking News
Quotes
All Instrument Types
  • All Instrument Types
  • Indices
  • Equities
  • ETFs
  • Funds
  • Commodities
  • Currencies
  • Crypto
  • Bonds
  • Certificates

Please try another search

Search website for: 
Popular News
More
Popular Analysis
More
More
/Free Sign Up
 Investing Pro 0
💎 Access the Market Tools Trusted by Thousands of Investors Get Started
Close

Pfizer Inc (PFE)

Create Alert
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Create Manage my alerts 
Back
Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
 
Create New Watchlist Create
Create a new holdings portfolio Add Create
+ Add another position Close
33.45 -1.15    -3.32%
21/09 - Delayed Data. Currency in USD ( Disclaimer )
Type:  Equity
Market:  Peru
ISIN:  US7170811035 
S/N:  PFE
  • Volume: 500
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 33.45 - 33.45
Pfizer 33.45 -1.15 -3.32%

NYSE:PFE Financials

 
A brief overview of the NYSE:PFE financials. This summary provides an overview of the most significant critical numbers from each of its financial reports, including the income statement, balance sheet, and cash flow statement. Additionally, it features several financial ratios that provide insight into the company's financial health. Users can select to view data from four periods of either annual or quarterly information, allowing them to track financial performance of Pfizer over time.

Pfizer Inc. reported earnings results for the second quarter and six months ended July 02, 2023. For the second quarter, the company reported sales was USD 12,734 million compared to USD 27,742 million a year ago. Net income was USD 2,327 million compared to USD 9,906 million a year ago. Basic earnings per share from continuing operations was USD 0.41 compared to USD 1.76 a year ago. Diluted earnings per share from continuing operations was USD 0.41 compared to USD 1.73 a year ago. Basic earnings per share was USD 0.41 compared to USD 1.77 a year ago. Diluted earnings per share was USD 0.41 compared to USD 1.73 a year ago.For the six months, sales was USD 31,015 million compared to USD 53,402 million a year ago. Net income was USD 7,870 million compared to USD 17,769 million a year ago. Basic earnings per share from continuing operations was USD 1.4 compared to USD 3.17 a year ago. Diluted earnings per share from continuing operations was USD 1.38 compared to USD 3.09 a year ago. Basic earnings per share was USD 1.4 compared to USD 3.17 a year ago. Diluted earnings per share was USD 1.38 compared to USD 3.1 a year ago.

AnnualQuarterly  
InvestingPro Advanced Financial Summary
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

PFE Income Statement

Gross margin TTM 69.82%
Operating margin TTM 32.53%
Net Profit margin TTM 27.55%
Return on Investment TTM 14.89%
 Total Revenue  Net Income
Period Ending: Jul 02, 2023 Apr 02, 2023 Dec 31, 2022 Oct 02, 2022
Total Revenue 12734 18282 24290 22638
Gross Profit 9802 13535 14299 16601
Operating Income 2657 6662 5699 10149
Net Income 2327 5543 4994 8608

PFE Balance Sheet

Quick Ratio MRQ 1.59
Current Ratio MRQ 2.12
LT Debt to Equity MRQ 62.29%
Total Debt to Equity MRQ 66.32%
 Total Assets  Total Liabilities
Period Ending: Jul 02, 2023 Apr 02, 2023 Dec 31, 2022 Oct 02, 2022
Total Assets 220168 195617 197205 195350
Total Liabilities 120875 94381 101288 102460
Total Equity 99293 101236 95917 92890

PFE Cash Flow Statement

Cash Flow/Share TTM 2.58
Revenue/Share TTM 13.81
Operating Cash Flow  -3.49%
 Cash  Net Change in Cash
Period Ending: Jul 02, 2023 Apr 02, 2023 Dec 31, 2022 Oct 02, 2022
Period Length: 0 Months 0 Months 0 Months 0 Months
Cash From Operating Activities -1208 1212 8582 5974
Cash From Investing Activities -25485 3315 -4410 -627
Cash From Financing Activities 27174 -2771 -5015 -5761
Net Change in Cash 475 1754 -869 -487
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I Agree

PFE Comments

Write your thoughts about Pfizer Inc
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Jay Clerk
Jay Clerk Sep 28, 2023 1:35PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Tanking again and again beautiful!
Reply
0 0
Report
sayed Elsayed
sayed Elsayed Sep 27, 2023 1:19PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
This stock is Collapsing
Reply
1 1
Report
Jay Clerk
Jay Clerk Sep 27, 2023 1:19PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Just wait for earnings then it will ve to late to get out! Proud bagholder
Reply
0 0
Report
George Galloway
George Galloway Sep 22, 2023 1:41PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
sad company with zero leadership and zero vision.
Reply
3 1
Report
damian del
mudlog79 Sep 22, 2023 10:44AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
dump this trash
Reply
2 1
Report
Hisham Chehab
Hisham Chehab Sep 21, 2023 2:20PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Can anyone provide a good vision for this stock plz.
Reply
0 2
Report
Thị Mỹ Thuận Trần
Thị Mỹ Thuận Trần Sep 21, 2023 2:20PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
30 $ soon
Reply
1 1
Report
Crim Jamer
Crim Jamer Sep 21, 2023 2:20PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Just believe what you see. I bought calls on last friday, they are almost total loss now.
Reply
0 0
Report
Jay Clerk
Jay Clerk Sep 21, 2023 2:20PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
If you get your bews from the mainstream then your bound to ve a victim , you just wont get it . Been shorting since 52$ havent let up once its going to 20s! This company is run by satan!
Reply
0 0
Report
Jay Clerk
Jay Clerk Sep 18, 2023 6:23PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Poopiest stock that ever circled the toilet
Reply
5 1
Report
George Galloway
George Galloway Sep 13, 2023 1:45PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
change at CEO is very much needed
Reply
5 0
Report
liebe dich ich
liebe dich ich Sep 13, 2023 6:05AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
wtf Pfizer stock? CEO should retire and get down his salary!
Reply
3 0
Report
Jay Clerk
Jay Clerk Sep 12, 2023 6:48AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Nobody with common sense will be getting another death jabbed. You have to be crazy to put that poisen in your viens
Reply
4 8
Report
aux fipe
aux fipe Sep 12, 2023 6:48AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Hooked on Phonics is a great tool.
Reply
0 0
Report
Anand Guru
Anand Guru Sep 11, 2023 10:06PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Read as FDA approval
Reply
0 0
Report
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Cancel Attach
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Confirm Block Cancel
Ok
Report this comment

I feel that this comment is:

Submit
Comment flagged

Thank You!

Your report has been sent to our moderators for review
Close
Continue with Google
or
Sign up with Email